|
RMI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.739700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.957630E-02 |
| Normal-vs-Stage2 |
3.379200E-01 |
| Normal-vs-Stage3 |
5.594100E-02 |
| Normal-vs-Stage4 |
6.772800E-01 |
| Stage1-vs-Stage2 |
3.595200E-01 |
| Stage1-vs-Stage3 |
7.881800E-01 |
| Stage1-vs-Stage4 |
3.087400E-01 |
| Stage2-vs-Stage3 |
5.359000E-01 |
| Stage2-vs-Stage4 |
7.840000E-01 |
| Stage3-vs-Stage4 |
4.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.097500E-02 |
| Normal-vs-AfricanAmerican |
2.130300E-02 |
| Normal-vs-Asian |
1.288570E-01 |
| Caucasian-vs-AfricanAmerican |
5.365200E-01 |
| Caucasian-vs-Asian |
7.132000E-01 |
| AfricanAmerican-vs-Asian |
8.516200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.238100E-02 |
| Normal-vs-Female |
4.090800E-01 |
| Male-vs-Female |
6.936000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.293600E-02 |
| Normal-vs-Extreme_Weight |
1.141630E-02 |
| Normal-vs-Obese |
2.115600E-01 |
| Normal-vs-Extreme_Obese |
2.098200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.209800E-01 |
| Normal_Weight-vs-Obese |
3.827200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.680600E-01 |
| Extreme_Weight-vs-Obese |
1.176610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.398600E-01 |
| Obese-vs-Extreme_Obese |
2.273400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.125600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.182800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.019200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.921570E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.932000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.453900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.752000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997650E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.052210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.555600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.009570E-01 |
| Normal-VS-Type2 PRCC |
3.081100E-03 |
| Normal-VS-KIRP CIMP |
5.875600E-01 |
| Normal-VS-Unclassified PRCC |
5.882800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.436500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.371570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.544600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.699900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.762200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.643400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.374100E-04 |
| Normal-vs-N1 |
9.628400E-01 |
| Normal-vs-N2 |
1.976170E-01 |
| N0-vs-N1 |
3.508500E-02 |
| N0-vs-N2 |
8.257200E-01 |
| N1-vs-N2 |
4.266800E-01 |
|
|
